Autolus Therapeutics plc
AUTL
$2.12
-$0.11-4.73%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -71.60M | -90.33M | -79.12M | -47.92M | -70.16M |
| Total Depreciation and Amortization | 2.70M | 2.63M | 2.54M | 2.37M | 2.28M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 20.09M | 19.40M | 21.03M | -4.31M | 10.02M |
| Change in Net Operating Assets | -16.50M | 983.00K | -12.35M | -22.92M | -17.70M |
| Cash from Operations | -65.32M | -67.32M | -67.90M | -72.78M | -75.57M |
| Capital Expenditure | -2.69M | 885.00K | -4.41M | -7.28M | -8.24M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 98.84M | 85.66M | 39.96M | 103.19M | -51.30M |
| Cash from Investing | 96.15M | 86.54M | 35.55M | 95.92M | -59.55M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.06M | -1.80M | -1.77M | -768.00K | -- |
| Cash from Financing | -2.06M | -1.80M | -1.77M | -768.00K | -- |
| Foreign Exchange rate Adjustments | -1.99M | 589.00K | -3.58M | 5.72M | 3.56M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 26.78M | 18.01M | -37.71M | 28.08M | -131.55M |